Oral daily weight loss medication (triple agonist: GLP/GIP/Glucagon) for overweight/obese patients without diabetes.
Status: Upcoming
Compensation: $4564
Location: Greenville - 545 Verdae Blvd., Lower Level, Suite B
Number of Visits: Discussed at screening
Age Group: 18-75
Qualifications: BMI ≥ 30 or a BMI of ≥ 27 with an additional weight related diagnosis, e.g. high blood pressure, high cholesterol, sleep apnea, MASH, or heart disease. | Must not have taken a GLP or weight-lowering medications within the last 6 months.
Location(s):
Greenville - 545 Verdae Blvd., Lower Level, Suite B
*You may receive compensation for your time and completed study visits.